Author: A4R Admin
- Filter byAll
- Filter byA4R – Alliance4Rare
- Filter byDates
- Filter byDonations
- Filter byEvents
- Filter byFilm portraits
- Filter byInformation & Opinion
- Filter byMedical Trainings
- Filter byOn our on behalf
- Filter byResearch
- Filter byTenders
-
A4R – Alliance4Rare
University Hospital Tübingen Becomes New Site Partner of Research Initiative Alliance4Rare
A strong network grows even stronger: With support from the Wilfried and Martha Ensinger Foundation, University Hospital Tübingen can now become the fifth location in the Alliance4Rare network.
-
Dates
CME Training “Pneumo Live” – Rare Diseases: Lungs 2025
Rare diseases of the lung are the focus of a live webinar in the PneumoLive series on the STREAMED UP training platform on Thursday, December 11, 2025 from 6:00 to…
-
Dates
CME Training “Paediatrics Live” – Rare Haematological Diseases in Paediatrics
Rare haematological diseases in paediatrics are the focus of a live webinar in the PaediatricsLive series on the training platform STREAMED UP on Monday, December 15, 2025, from 6:00 to…
-
Dates
Transition in Rare Diseases: Smooth Entry into Adult Medicine
Save the date: The live talk on October 13, 2025, will take place from 6:00 to 7:30 p.m. as an interactive live webinar on the STREAMED UP video platform. On…
-
Dates
Red Flag Webinar: Diagnostics of Neuronal Ceroid Lipofuscinoses
Neuronal ceroid lipofuscinoses (NCL) are the most common types of neurodegenerative diseases in childhood and adolescence. NCL specialist Dr. med. Angela Schulz from UKE Hamburg-Eppendorf provides an overview of the…
-
Dates
Tagesspiegel Health Forum: Women with Rare Diseases
Event notice: The Tagesspiegel Health Forum invites you to the event Women with Rare Diseases under the title "Double hurdle? When rarity and gender impact care," on Wednesday, September 24,…
-
Dates
CME Training: “Treatment of Genetic Forms of Diabetes and Obesity”
What specific approaches currently exist for treating genetic forms of diabetes and obesity? How can genetic diagnoses such as cystic fibrosis or MODY influence therapy selection? What therapeutic options are…